Developer docs
API playgroundTry for free, no card

Search company profiles

Clinigen South Africa

Full company profile

uuid00sd7e8

Namestring
Clinigen South Africa
Legal namestring
Clinigen South Africa
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Clinigen South Africa is an entity referenced under the legal name "Clinigen South Africa" with a web presence at clinigensa.co.za. The "South Africa" suffix and.co.za country-code top-level domain indicate a South African operating locus, and the shared "Clinigen" name is consistent with a local subsidiary, branch, or affiliated operation tied to the broader Clinigen corporate identity. No further functional description can be grounded in the supplied input: the source page returned only a "One moment, please... Loader" verification placeholder rather than substantive company content, and as a result every operational field — company type, founded date, operating status, products and services, business model, pricing, customers, headquarters address, and headcount — is either empty or explicitly unavailable.

On the evidence available, nothing can be stated about Clinigen South Africa's products, underlying technology, go-to-market motion, revenue mechanics, customer segments, or competitive positioning. The input contains no information on whether the entity actively distributes, licenses, or supplies products; whether it serves pharmaceutical manufacturers, healthcare providers, or patients; whether it operates as a regulated distributor, a clinical trial supply partner, or a commercial affiliate; or whether it is operational, dormant, or a marketing/legal shell. Ownership, parent-company relationship, and corporate structure are likewise unspecified in the input.

The primary characteristic of this record is therefore a near-total data gap. Any analytical conclusion beyond the legal name, the South African geographic indication implied by the domain, and the loading-state status of the source page would be unsupported inference. Investors and counterparties evaluating Clinigen South Africa would need to obtain first-party corporate, regulatory, and financial disclosures — South African company registry filings, pharmaceutical sector licenses, and audited financials if available — before forming a view on the entity's function, scale, or strategic role within any larger Clinigen group.

Short descriptiontext

Clinigen South Africa is a South Africa–based entity operating under the Clinigen name via the clinigensa.co.za domain. Its specific products, customers, business model, and operating status cannot be determined from the available source data.

Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersPretoria, South Africa
HQ citystring
Pretoria
HQ countrystring
South Africa
HQ regionstring
Africa
Markets served

Serves global market

Keyword5 values
pharmaceutical distribution, clinical trial supply, unlicensed medicine access, hospital healthcare services, specialty medicines
Industry1 code
1Pharmacovigilance, Risk Management & Medical Affairs CROs
CodeHLAGAAAHPrimaryNo
NAICS code1 code
  • All Other Support Services561990
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Pharmaceutical Services
Social media profiles1 record
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Clinigen South Africa operates as a regional presence of Clinigen Group, a specialty global pharmaceutical and services company. Based on the group context, the entity would be expected to facilitate access to medicines (including unlicensed, licensed, and clinical trial supplies), commercialise therapies, and provide healthcare services to hospitals, clinicians, and patients in South Africa. However, the source page for clinigensa.co.za displays only a loading/verification placeholder, so no confirmed offering details are evidenced in the input.

Differentiator
Functional benefit
Problem solved
No data
Peers10 records
TypeRegional player
Description

Largest South African-headquartered pharmaceutical manufacturer and distributor with deep Sub-Saharan reach; comparable as a regional pharma services and distribution player in Clinigen South Africa's home market.

TypeDirect peer
Description

UPS-owned clinical trial logistics specialist providing time-sensitive global distribution of investigational medicines, biological samples, and comparator drugs; directly comparable to Clinigen's clinical supply chain services.

TypeDirect peer
Description

Cencora-owned specialty logistics provider for clinical trials, cell and gene therapies, and high-value pharma; directly comparable as a clinical trial supply and distribution peer.

TypeDirect peer
Description

Specialist global supplier of unlicensed, comparator, and clinical trial medicines; directly comparable to Clinigen's core clinical trial supply and managed access offering across international markets.

TypeBroad incumbent
Description

Largest global CRO and life sciences services platform with broad clinical trial, technology, and distribution capabilities; competes with Clinigen across multiple service lines as a broad incumbent rather than a niche specialist.

TypeDirect peer
Description

Global clinical trial services and pharma supply chain provider offering comparator sourcing, packaging, labelling, and distribution; directly overlaps with the clinical trial supply portion of Clinigen's business.

TypeEmerging player
Description

Specialty provider of managed access, early access, and clinical trial supply programs for biopharma; comparable as a niche emerging peer focused specifically on managed access programs, which is a core Clinigen offering.

TypeBroad incumbent
Description

Global clinical research organisation providing full-service Phase I-IV trial delivery; operates as a broad incumbent in the same end-market as Clinigen's clinical trial customers.

TypeBroad incumbent
Description

Global pharma services platform (now under Novo Holdings) providing development, manufacturing, and clinical supply services; competes with Clinigen across clinical supply and biologics services as a broad incumbent.

TypeRegional player
Description

Major South African pharmaceutical manufacturer and distributor with broad presence across prescription, OTC, and hospital products; comparable as a regional pharma distribution peer operating in the same geography.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Clinigen South Africa

Pharmaceutical Servicesclinigensa.co.za

Clinigen South Africa is a South Africa–based entity operating under the Clinigen name via the clinigensa.co.za domain. Its specific products, customers, business model, and operating status cannot be determined from the available source data.

What Clinigen South Africa does

Clinigen South Africa is an entity referenced under the legal name "Clinigen South Africa" with a web presence at clinigensa.co.za. The "South Africa" suffix and.co.za country-code top-level domain indicate a South African operating locus, and the shared "Clinigen" name is consistent with a local subsidiary, branch, or affiliated operation tied to the broader Clinigen corporate identity. No further functional description can be grounded in the supplied input: the source page returned only a "One moment, please... Loader" verification placeholder rather than substantive company content, and as a result every operational field — company type, founded date, operating status, products and services, business model, pricing, customers, headquarters address, and headcount — is either empty or explicitly unavailable.

On the evidence available, nothing can be stated about Clinigen South Africa's products, underlying technology, go-to-market motion, revenue mechanics, customer segments, or competitive positioning. The input contains no information on whether the entity actively distributes, licenses, or supplies products; whether it serves pharmaceutical manufacturers, healthcare providers, or patients; whether it operates as a regulated distributor, a clinical trial supply partner, or a commercial affiliate; or whether it is operational, dormant, or a marketing/legal shell. Ownership, parent-company relationship, and corporate structure are likewise unspecified in the input.

The primary characteristic of this record is therefore a near-total data gap. Any analytical conclusion beyond the legal name, the South African geographic indication implied by the domain, and the loading-state status of the source page would be unsupported inference. Investors and counterparties evaluating Clinigen South Africa would need to obtain first-party corporate, regulatory, and financial disclosures — South African company registry filings, pharmaceutical sector licenses, and audited financials if available — before forming a view on the entity's function, scale, or strategic role within any larger Clinigen group.

Clinigen South Africa firmographics

Firmographics
Name
Clinigen South Africa
Legal name
Clinigen South Africa
Website
https://clinigensa.co.za
Company type
Private
Headcount range
251–500 employees
Short description
Clinigen South Africa is a South Africa–based entity operating under the Clinigen name via the clinigensa.co.za domain. Its specific products, customers, business model, and operating status cannot be determined from the available source data.
Ownership category
akta.pro rank

Where Clinigen South Africa is headquartered

Location

Headquarters

HQ city
Pretoria
HQ country
South Africa
HQ region
Africa

Markets served

Clinigen South Africa business model

Business model
GTM type
B2B
Offering type
Services

Clinigen South Africa product offering

Product offering

Core offering

Clinigen South Africa operates as a regional presence of Clinigen Group, a specialty global pharmaceutical and services company. Based on the group context, the entity would be expected to facilitate access to medicines (including unlicensed, licensed, and clinical trial supplies), commercialise therapies, and provide healthcare services to hospitals, clinicians, and patients in South Africa. However, the source page for clinigensa.co.za displays only a loading/verification placeholder, so no confirmed offering details are evidenced in the input.

Differentiator

Problem solved

Functional benefit

Companies that use Clinigen South Africa

Customer profile

Ideal customer profiles1 record

Clinigen South Africa technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Clinigen South Africa competitors and assessment

Company assessment

Regional players

  • Aspen Pharmacare: Largest South African-headquartered pharmaceutical manufacturer and distributor with deep Sub-Saharan reach; comparable as a regional pharma services and distribution player in Clinigen South Africa's home market.
  • Adcock Ingram: Major South African pharmaceutical manufacturer and distributor with broad presence across prescription, OTC, and hospital products; comparable as a regional pharma distribution peer operating in the same geography.

Direct peers

  • Marken: UPS-owned clinical trial logistics specialist providing time-sensitive global distribution of investigational medicines, biological samples, and comparator drugs; directly comparable to Clinigen's clinical supply chain services.
  • World Courier: Cencora-owned specialty logistics provider for clinical trials, cell and gene therapies, and high-value pharma; directly comparable as a clinical trial supply and distribution peer.
  • Clinical Services International: Specialist global supplier of unlicensed, comparator, and clinical trial medicines; directly comparable to Clinigen's core clinical trial supply and managed access offering across international markets.
  • PCI Pharma Services: Global clinical trial services and pharma supply chain provider offering comparator sourcing, packaging, labelling, and distribution; directly overlaps with the clinical trial supply portion of Clinigen's business.

Broad incumbents

  • IQVIA: Largest global CRO and life sciences services platform with broad clinical trial, technology, and distribution capabilities; competes with Clinigen across multiple service lines as a broad incumbent rather than a niche specialist.
  • ICON plc: Global clinical research organisation providing full-service Phase I-IV trial delivery; operates as a broad incumbent in the same end-market as Clinigen's clinical trial customers.
  • Catalent: Global pharma services platform (now under Novo Holdings) providing development, manufacturing, and clinical supply services; competes with Clinigen across clinical supply and biologics services as a broad incumbent.

Emerging players

  • Bionical Solutions: Specialty provider of managed access, early access, and clinical trial supply programs for biopharma; comparable as a niche emerging peer focused specifically on managed access programs, which is a core Clinigen offering.

Market position

Strengths4 records

Weaknesses4 records

Customer concentration

Clinigen South Africa social profiles

Digital presence

Clinigen South Africa financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Clinigen South Africa leadership team

Management profile

Number of profiles

Clinigen South Africa funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Clinigen South Africa M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinigen South Africa

What does Clinigen South Africa do?

Clinigen South Africa operates as a regional presence of Clinigen Group, a specialty global pharmaceutical and services company. Based on the group context, the entity would be expected to facilitate access to medicines (including unlicensed, licensed, and clinical trial supplies), commercialise therapies, and provide healthcare services to hospitals, clinicians, and patients in South Africa. However, the source page for clinigensa.co.za displays only a loading/verification placeholder, so no confirmed offering details are evidenced in the input.

When was Clinigen South Africa founded?

Clinigen South Africa was founded in -1. It employs 251 to 500 people.

Where is Clinigen South Africa based?

Clinigen South Africa is headquartered in Pretoria, South Africa, in the Africa region.

Who are Clinigen South Africa's main competitors?

Regional players on record are Aspen Pharmacare and Adcock Ingram. Direct peers are Marken, World Courier, Clinical Services International and PCI Pharma Services. Broad incumbents are IQVIA, ICON plc and Catalent. Bionical Solutions is listed as an emerging player.

Does Clinigen South Africa have an API?

No public API is recorded for Clinigen South Africa.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales